Llinks Law Offices has established a strong IPOs focussed practice, with lawyers also offering FDI, compliance, M&A and commercial law experience. The firm is well recommended for assistance provided to Chinese clients developing innovative medical technologies and introducing these products to the market, and is noted by clients for providing ‘all-round integrated services’. The key lawyers in the team are cross-border investment specialist David Yu, intellectual property matters expert Xun Yang and the IPOs focussed Wayne Chen.
Testimonials
Collated independently by Legal 500 research team.
‘The law firm can provide clients with efficient and accurate legal services based on historical project experience and the latest industry trends.’
‘Able to provide clients with investment and compliance consulting, industry research and other all-round integrated services. Their response speed exceeds expectations.’
Key clients
- Jiangsu Bioperfectus Technologies Company, Ltd
- Zhejiang UE Medical Corp.
- Shenzhen Chipscreen Biosciences Co.,Ltd
- Shanghai Henlius Biotech, Inc.
- ShangHai Allist Pharmaceuticals Inc
- Alihealth Technology (China) Co.,Ltd.
- Shanghai Fushi Medical Technology Co., Ltd.
- Shanghai Cell Therapy Group Co. Ltd.
- Ortho-Clinical Diagnostics Trading (China) Co., Ltd.
- Shengzhong Hospital Management (Shanghai) Co., Ltd.